Soluprick Controls

• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or nurse.
• This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
• If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet:

1. What Soluprick is and what it is used for
2. What you need to know before you use Soluprick
3. How to use Soluprick
4. Possible side effects
5. How to store Soluprick
6. Contents of the pack and other information

• If you are allergic to any of the ingredients in Soluprick Positive and Negative Control apart from the active substance (listed in section 6).

Please inform your doctor if this statement applies to you.

Talk to your doctor before using Soluprick Positive and Negative Control.

• If you have skin problems in the area the skin-prick test is to be applied
• If you suffer from a disease which is affecting your general health

Tell your doctor or healthcare professional if you are taking, have recently taken or might take any other medicines including those obtained without a prescription.

Some medicines can affect the results of the skin prick test, therefore: Tell your doctor or healthcare professional before the skin prick test is carried out if you are taking any of the following medicines:

• Short-acting antihistamines within the last three days;
• Long-acting antihistamines within the last week;
• Steroids at doses higher than 10 mg prednisolone per day;
• Strong steroid preparations applied to your skin within the last three weeks

Tablet treatment with less than 10 mg prednisolone per day will not suppress the reaction to the skin prick test.

Other medicines may interfere with the result of the skin prick test. You should discuss with your doctor the risk of discontinuing treatment compared with the benefits of having a skin prick test.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.

There are no adequate data from the use of Soluprick Positive and Negative Control in pregnant women. This product should not be used in pregnant women unless the benefits are considered by the treating physician to outweigh the risks.

Skin prick testing can be performed if you are breast feeding.

Soluprick Positive and Negative Controls have no influence on the ability to drive and use machines.

Skin prick test with Soluprick is given by a healthcare professional. In the event of an overdose, you will be monitored and treated by a healthcare professional.

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for “MHRA Yellow Card” in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

The active substance in Soluprick Positive Control is Histamine Dihydrochloride.

There is no active substance in Soluprick Negative Control.

The other ingredients are phenol, sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium chloride, glycerol, water for injection, sodium hydroxide and hydrochloric acid.

Soluprick is supplied in a glass vial containing 2 ml clear solution.

The vial is closed with a rubber stopper and a screw cap.